Personalis Inc

For the period ended Sep 30, 2024. Filed Nov 6, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 6, 2024

PSNL$15.88-0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Equity

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited)

For the Three Months Ended September 30, 2024 and 2023

(in thousands, except share data)

	Accumulated
Additional · Other · Total
Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders'
	Shares	Amount	Capital	Income (Loss)	Deficit	Equity
Balance—June 30, 2024	53,052,847	$5	$606,863	$(120)	$(494,476)	112,272
Exercise of Tempus Warrants	9,218,800	1	46,738	—	—	46,739
Proceeds from sale of common stock under Tempus Investment Agreement, net of issuance costs	3,500,000	—	16,605	—	—	16,605
Proceeds from sales of common stock under ATM facility, net of commissions	4,760,588	1	27,235	—	—	27,236
Proceeds from exercise of stock options	46,471	—	114	—	—	114
Restricted stock units vested	59,484	—	—	—	—	—
Stock-based compensation	—	—	2,677	—	—	2,677
Foreign currency translation adjustment	—	—	—	61	—	61
Unrealized gain on available-for-sale debt securities	—	—	—	146	—	146
Net loss	—	—	—	—	(39,089)	(39,089)
Balance—September 30, 2024	70,638,190	$7	$700,232	$87	$(533,565)	$166,761
Balance—June 30, 2023	48,507,101	$5	$589,418	$(313)	$(413,024)	$176,086
Proceeds from sales of common stock under ATM facility, net of commissions	429,214	—	725	—	—	725
Restricted stock units vested	77,168	—	—	—	—	—
Stock-based compensation	—	—	3,482	—	—	3,482
Foreign currency translation adjustment	—	—	—	(42)	—	(42)
Unrealized gain on available-for-sale debt securities	—	—	—	53	—	53
Net loss	—	—	—	—	(29,098)	(29,098)
Balance—September 30, 2023	49,013,483	$5	$593,625	$(302)	$(442,122)	$151,206

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited)

For the Nine Months Ended September 30, 2024 and 2023

(in thousands, except share data)

	Accumulated
Additional · Other · Total
Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders'
	Shares	Amount	Capital	Income (Loss)	Deficit	Equity
Balance—December 31, 2023	50,480,694	$5	$598,364	$(222)	$(468,706)	$129,441
Exercise of Tempus Warrants	9,218,800	1	46,738	—	—	46,739
Proceeds from sale of common stock under Tempus Investment Agreement, net of issuance costs	3,500,000	—	16,605	—	—	16,605
Proceeds from sales of common stock under ATM facility, net of commissions	6,660,731	1	30,077	—	—	30,078
Proceeds from exercise of stock options	46,471	—	114	—	—	114
Proceeds from ESPP	391,415	—	317	—	—	317
Restricted stock units vested	340,079	—	—	—	—	—
Stock-based compensation	—	—	8,017	—	—	8,017
Foreign currency translation adjustment	—	—	—	233	—	233
Unrealized gain on available-for-sale debt securities	—	—	—	76	—	76
Net loss	—	—	—	—	(64,859)	(64,859)
Balance—September 30, 2024	70,638,190	$7	$700,232	$87	$(533,565)	$166,761
Balance—December 31, 2022	46,707,084	$5	$579,456	$(912)	$(360,410)	$218,139
Proceeds from sales of common stock under ATM facility, net of commissions	1,329,214	—	2,598	—	—	2,598
Proceeds from exercise of stock options	8	—	—	—	—	—
Proceeds from ESPP	468,643	—	909	—	—	909
Restricted stock units vested	508,534	—	—	—	—	—
Stock-based compensation	—	—	10,662	—	—	10,662
Foreign currency translation adjustment	—	—	—	(51)	—	(51)
Unrealized gain on available-for-sale debt securities	—	—	—	661	—	661
Net loss	—	—	—	—	(81,712)	(81,712)
Balance—September 30, 2023	49,013,483	$5	$593,625	$(302)	$(442,122)	$151,206

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.